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Summary Neurofeedback (NF) is a training to enhance self-
regulatory capacity over brain activity patterns and consequently
over brain mental states. Recent findings suggest that NF is a
promising alternative for the treatment of attention-deficit/hyper-
activity disorder (ADHD).We comprehensively reviewed litera-
ture searching for studies on the effectiveness and specificity of
NF for the treatment of ADHD. In addition, clinically informa-
tive evidence-based data are discussed. We found 3 systematic
review on the use of NF for ADHD and 6 randomized con-
trolled trials that have not been included in these reviews. Most
nonrandomized controlled trials found positive results with
medium-to-large effect sizes, but the evidence for effectiveness
are less robust when only randomized controlled studies are
considered. The direct comparison of NF and sham-NF in 3
published studies have found no group differences, nevertheless
methodological caveats, such as the quality of the training
protocol used, sample size, and sample selection may have
contributed to the negative results. Further data on specificity
comes from electrophysiological studies reporting that NF ef-
fectively changes brain activity patterns. No safety issues have
emerged from clinical trials and NF seems to be well tolerated
and accepted. Follow-up studies support long-term effects of
NF. Currently there is no available data to guide clinicians on the
predictors of response to NF and on optimal treatment protocol.
In conclusion, NF is a valid option for the treatment for ADHD,
but further evidence is required to guide its use.
Keywords Attention-deficit/hyperactivity disorder (ADHD) .
Neurofeedback . Biofeedback . EEG biofeedback . Slow
cortical potential . Theta/Beta training
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a com-
mon [1], chronic [2], and debilitating disorder [3–6].
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Although pharmacological treatments for ADHD can be
easily implemented and are usually effective, their
long-term therapeutic effects are still uncertain [7, 8]
and adverse events are common, especially sleep prob-
lems, decreased appetite, and growth deceleration. Fur-
thermore, psychosocial treatments, such eas parental
training and behavioral therapy seem to be effective
only during its delivery, and their effects are rarely
sustained long-term [7–9]. Considering the significant
limitations of current available interventions, it has become
a consensus among clinicians that new treatment options for
ADHD are needed. In recent years, neurofeedback (NF) has
been suggested as a promising possibility.
Neurofeedback, also known as electroencephalogram
(EEG) biofeedback, or brainwave biofeedback, is a training
to improve self-control over brain activity patterns and
consequently over brain mental states. Although feedback
can also be based on magnetic (magnetoencephalogram) or
on near real-time hemodynamic measures of brain activity
(near infrared spectroscopy, real-time functional magnetic
resonance imaging) apart from 1 study using tomographic
neurofeedback (tNF) [10], only the low cost EEG-based
neurofeedback has been used for ADHD treatment. Through
operant conditioning, individuals can be trained to control
brain electric activity and a growing body of evidence
shows that this can be helpful for the treatment of mental/
neurological conditions, such as epilepsy [11], brain injury
[12], chronic pain [13], ADHD [14], insomnia [15], and
others.
To date, 1 meta-analysis and 1 systematic review were
already published reporting findings of at least 14 random-
ized control trials on the effectiveness of NF for the treat-
ment of ADHD [14, 16]. In addition, several other
nonrandomized and noncontrolled studies can be found in
the literature. Arns et al’s [16] meta-analysis reports the
effect of NF for ADHD, including different types of studies
(controlled and noncontrolled, randomized and nonrandom-
ized) published prior to 2009. Lofthouse et al. [14] system-
atically reviewed the literature, searching exclusively for
randomized controlled studies. Although this last review
was published online in November 2011, it only covers
literature prior to September 2010. As scientific production
on NF is growing every year, a considerable amount of data
was not included in these 2 reviews. Only during the end of
2010, 2011, and 2012, there were 6 other randomized con-
trolled studies that were published [10, 17–21], with 3 of
them using sham-NF as a control group [17, 19, 20]. An-
other review covers more recent literature, but it is only
available in German [22].
This article aims to review the existing evidence and
inform clinicians on the use of NF as an alternative treat-
ment for ADHD. In addition, clinically informative evidence-
based data are discussed.
Background
Neurofeedback was introduced with the development of
biofeedback during the 1960s. During the 1950s and
1960s, inspired by behaviorists ideas, Neal Miller, a re-
searcher at Yale, proposed that it was possible to teach
animals and humans to gain control of their autonomic
functions [23]. The first experiments investigating classical
conditioning of brain electrical activity dates back to the
1930s [24], but therapeutic applications were introduced
several years later. Joe Kamiya is considered by many as
the “father” of modern NF. During the 1960s, Kamiya
developed a series of experiments showing that certain
individuals could be trained to intentionally control its brain
electrical activity and enter the “alpha state,” a mental state
associated with feelings of relaxation [25]. In 1965, Sterman
was studying sleep [26] when he accidentally discovered
that cats could be conditioned to produce a fast EEG rhythm
of approximately 12 to 15 Hz over the sensorimotor cortex
(the sensorimotor rhythm [SMR]) [27]. Sterman used the
same cats in another experiment in which the animals would
be exposed to a toxic substance known to provoke seizures.
He was surprised by the observation that the animals that
had been taught to produce SMR were resistant to the
convulsive effect of such substance [27]. Sterman then
replicated his discovery in monkeys [28], in human open
trials [29], and finally in a blind, repeated measurements
controlled study [28], showing that NF could be used to
control seizures. Sterman’s report encouraged other
researchers to try NF for epilepsy and some of them even-
tually reported that children with both epilepsy and hyper-
kinetic symptoms showed surprising improvement of
hyperkinesia after NF sessions. In 1976, Lubar and Shouse
[30] were the first to report the benefit of NF for children
with hyperkinetic disorders without epilepsy [30, 31].
Brain Electric Activity and Its Relation to Brain
Function
Brain EEG signals can be filtered into frequency bands
specified in terms of frequency in Hertz (Hz), the number
of waves per second. The observation that certain EEG
frequency patterns are related to certain brain activities dates
back to the discovery of the EEG itself. When the German
psychiatrist Hans Berger recorded the first human brain
EEG, he also reported that slow-frequency waves were
associated with resting states, whereas faster waves would
appear in response to brain challenge (e.g., when performing
a math test) [32]. Low frequencies lower than 4 Hz (Delta
waves) are associated with sleep state; 4 to 7 Hz frequencies
(Theta) are associated with sleep and decreased vigilance;
Alpha waves (8-12 Hz) appears in relaxed/wakeful states,
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and fast 13 to 30 Hz waves (Beta) are related to concentra-
tion and neuronal excitability (for an overview see Table 1
in Banaschewski’s review [33]). SMR is a specific type of
low Beta frequency ranging from 12 to 15 Hz observed over
the sensorimotor cortex that is correlated with immobility
[27]. Considering that some authors found a positive asso-
ciation between ADHD and higher Theta/Beta ratio [34]
most NF protocols for ADHD treatment aim at increasing
faster Beta frequencies, especially SMR, and decrease Theta
waves. In practical terms, this training is simple and only
requires an EEG amplifier plus some software or apparatus
to generate continuous feedback and conditional reinforce-
ment based on power in the critical EEG bands. In clinical
practice, a computer interface (a computer game) translates
for the patient how close he is to generating the target brain
wave pattern. Electrodes are placed along the scalp and
individuals are required to remain seated in front of a com-
puter screen trying to find mental strategies to gain points.
The computer reads the EEG signal and visual or auditory
feedback is instantly generated. Changes in EEG activity
made in a desired direction are rewarded. Although some
differences exist in regard to frequency and number of
sessions, in general NF is an intense treatment in which
the patients have appointments 2 to 3 times per week
(sometimes even more) having to remain seated and quiet,
trying to focus on a monotonous task for 30 to 60 minutes
each session.
In recent years, slow cortical potential (SCP) NF has
emerged as a novel NF protocol for the treatment of ADHD.
SCPs are a type of event-related potentials (ERPs). ERPs are
EEG signals that appear in anticipation, or in response to the
presentation of a stimulus or event. SCPs reflect the excit-
ability level of underlying cortical regions; deflection in the
negative direction appears to reflect higher excitability and
positive shifts that are associated with reduced excitability
or inhibition [35]. In SCP training, subjects are taught to
intentionally alternate from negative to positive deflections;
that means, subjects are trained to be able to produce both
positive and negative shifts and consequently to intention-
ally and instantaneously shift brain mental state from re-
laxed to attentive and vice versa. This training aims to
regulate the cortical excitation threshold that is possibly
impaired in children with ADHD [10, 36, 37].
Is NF an Effective Treatment for ADHD and Is Its
Efficacy in ADHD Based on a Specific Compounds?
To date, a considerable amount of studies already examined
the effect of NF for the treatment of ADHD (see Table 1).
Almost unequivocally, uncontrolled within subjects’ pre- to
post-treatment analyses indicate positive results with
medium-to-large effect sizes (ES) [16, 18, 21, 35, 38–47].
Arns et al. [16] computed data from 12 studies. They found
a pooled within subjects ES of 1.02 for inattention; 0.71 for
hyperactivity; and 0.94 for impulsivity. These results, how-
ever, may be influenced by the placebo effect, because the
ES for controlled studies is considerably lower, although
still impressive. In the same meta-analysis, NF was superior
to passive or semi-active control groups with a pooled
estimated ES of 0.81 for inattention; 0.4 for hyperactivity,
and 0.69 for impulsivity. Nevertheless, only 4 of 10 studies
used a randomized design and parent’s attitude in regard to
treatment (preference for NF) may have lead to overestima-
tion of its effect. Furthermore, in none of the studies, inves-
tigators were blind to the participant’s group assignment and
parents were not aware of it in only 2 studies. In addition,
only 1 study [18] used a truly equivalent control group that
received electromyogram (EMG) biofeedback as a kind of
sham-NF. Other control conditions may be problematic
because the “high-tech” environment associated with NF
or biofeedback can enhance parents and children expecta-
tion about positive treatment results. More recently, Loft-
house et al. [14] conducted a systematic review and reported
the findings of 14 randomized controlled trials. These
authors were able to identify 8 unpublished studies not
included in Arns’ review [14]. Lofthouse et al. [14] were
fairly more restrictive than the previous meta-analysis in
regard to the minimal acceptable methodological quality of
studies but found comparable ES of 0.69 (95 % CI 0.34-
1.66) for overall ADHD symptoms, 0.79 (95 % CI 0.41-
1.62) for inattention, and 0.71 (95 % CI 0.35-1.55) for
hyperactivity/impulsivity. Since the publication of this re-
view, however, 6 additional, well-conducted studies were
published on the effectiveness of NF for treatment of chil-
dren with ADHD [10, 19–21, 48], 1 for adult ADHD [49],
and 1 for attentional problems in healthy adult subjects [17].
Three of these studies used a sham-controlled design [17,
19, 48], which is crucial to demonstrate that the effects seen
in clinical trials are specifically related to the EEG training
itself and not to nonspecific aspects of the treatment. It is
possible that part of the effect of NF comes from nonspecific
aspects of the attention training. It should be noted that
many authors have argued that the use of sham-NF as a
control group is unnecessary (although individuals are not
told in which treatment group they are, it is easy for them to
guess if they are in the effective treatment group or in the
placebo group), unethical (ADHD is a debilitating disorder
with known efficacious treatments) and even not feasible
[50]. Although the ethical aspect is a debatable issue, it can
often be resolved by offering real treatment after study
completion and proof of superiority. The idea of feasibility
is debatable, and the integrity of blinding procedures was
verified in the 4 published sham-controlled studies [17, 19,
20, 48], and in all of them, blinding procedures showed to
be achievable. Nevertheless, this result in favor of effective
590 Moriyama et al.
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blinding may partly reflect the negative results of all 4
studies. One the other hand, the negative findings might
have been determined by the use of suboptimal NF, because
all of these studies used very experimental protocols and in
none of them, the principals of learning theory were applied
to ensure that subjects were really under conditioning pro-
cedures (see Sherlin et al. work for a review on the topic
[24]). A summary of the findings from all sham- or EMG-
biofeedback-controlled studies assessing efficacy of NF for
ADHD can be found in Table 1. Four of these studies found
no significant group differences [17–20], and 1 lacks be-
tween groups comparison [48]. Lofthouse et al.’s [14] re-
view reports the findings of studies favoring NF in
comparison to sham-NF [14], but unfortunately these stud-
ies were not published in peer-reviewed journals. One of
essential to assure that patients are engaged with the training
task to check its efficacy. In this study, only patients who
showed good learning curves on NF training responded to
treatment. It should also be highlighted that with the excep-
tion of 2 studies that included 37 and 39 participants, all
other studies with negative results included very small sam-
ples and a type II error is possible. Furthermore, 1 of the 5
studies used adult healthy subjects and selected a population
(university students) with attentional problems, but not
ADHD [17]. It is possible that the lack of improvement
found in both groups (NF and sham-NF) is a consequence
of the insufficient room for improvement for such subjects.
A major problem is also that the type of neurofeedback used
in several sham- controlled studies did not follow standard
training and transfer procedures. Additional indirect infor-
mation on the specificity of NF comes from comparisons
with active treatments (see Table 2 for an overview of
randomized studies comparing NF to other control condi-
tions, and see Table 3 for nonrandomized studies). There are
3 studies [43, 46, 52] reporting findings of the direct com-
parison of NF and stimulants, but all of them are non-
randomized (Table 3). None of these studies found NF to
be inferior to medication, but comparison was restricted to
neuropsychological measurements in 2 of them. Drechsler et
al. [45] compared NF to cognitive behavioral therapy and
found NF to be superior to psychotherapy according to
parents and teachers ratings for inattention and metacog-
nition, but not according to objective neuropsychologi-
cal measurements. The 3 studies comparing NF to
computerized attention skills training (CAST) yielded
conflicting results. The largest study so far (including
94 individuals) found NF to be superior to CAST [39].
One study found no significant difference between groups,
although only the NF group improved in relation to baseline,
and the lack of difference may be due to the low power
provided by the small sample sizes [53].
Another way of examining the specificity of NF is
through electrophysiological study. We can obtain addition-
al evidence for the specificity of NF if it changes the EEG
pattern during and after the training toward the target state
(s), and if these changes are correlated with clinical im-
provement. Several trials also evaluated the effect of NF
on the EEG, and on learning EEG control during training.
Frequency training NF compared to sham-NF has been
found to effectively reduce Theta/Beta ratio during NF
training and in a resting state baseline [18], and both SCP
and frequency training can increase intentional control over
brain electrical activity [38], although this may only hold for
a subgroup of the ADHD children training with NF [45]. In
a large randomized trial, the authors found SCP (when
compared to CAST) to significantly decrease theta activity
after training, and increase both participants capacity to
modulate SCP, and Contingent Negative Variation (CNV)
[54–56]. In addition, increase of the central midline alpha
activity and decrease of the posterior midline theta activity
was associated with improvement in ADHD symptoms [55,
56]. Controlled studies also found frequency training to be
associated with a normalization of the frontal No-Go N2,
[53] which is correlated with response inhibition, and with a
decrease of cortical slowing [44]. Cannon et al. [57] used an
innovative design to study the effect of tNF based on the
estimated EEG source activity in the anterior cingulate
gyrus (ACC), a structure known to be important for atten-
tion and control. The authors treated 8 healthy subjects with
30 tNF sessions and analyzed changes in ACC source ac-
tivity across the sessions. They observed a significant in-
crease of current density within the cognitive division of the
ACC and in the anterior regions that receive its projections,
providing strong evidence that NF categorically changes
brain activity. In a follow-up study, the group reported
similar, correlated increases after tomographic ACC and
dorsolateral prefrontal cortex training [58]. Some authors,
however, could not find NF to produce significant changes
over EEG patterns [17, 19].
Alternatively, the effect of NF in the brain can be studied
with high spatial resolution through hemodynamic neuroimag-
ing. Beauregard and Lévesque [59] conducted a functional
magnetic resonance imaging study and found NF to normalize
the brain systems mediating selective attention and inhibitory
control. This is comparable with electrophysiological data,
strengthening the evidence for a specific effect of NF for
ADHD. However, a recent study [10] using tNF, which also
allows spatially specific feedback, showed that although it is
possible to target specific brain regions with tNF training, part
of the clinical improvement occurring with tNF may be due to
unspecific effects.
In summary, the available studies point to a possible
efficacy and specificity of NF for the treatment of ADHD,
but still additional large, randomized controlled studies
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using blind assessment procedures are needed to clarify this
issue. Sham or placebo control is an important standard ap-
proach to isolate specific effects, and another sham-controlled
study has been recently completed [20]. However, future sham
controlled studies should take greater care to ensure that NF
remains optimized for learning of self regulation, that it
includes transfer, and that it does not compromise the quality
of NF just to facilitate blinding. Currently, a large multicenter
randomized EMG biofeedback controlled study is being
conducted in Germany (http://controlled-trials.com/
ISRCTN76187185/neurofeedback), and important data
can be expected in the next few years.
Which ADHD Subtypes Benefit from NF?
Very few studies computed response ratio to NF and be-
cause sample sizes are small for the majority of studies,
most do not investigate possible predictors of response.
Gevensleben et al. [60] defined response ratio as a reduction
of at least 25 % in symptoms, and found 50 % of partic-
ipants to respond to NF, suggesting that some individuals
may benefit from NF, whereas others may not. Wangler et
al. [61] found baseline EEG patterns, specifically, an in-
crease of the CNV in an attention task, to be a predictor of
good response to SCP training. Age and IQ have also been
found to influence changes in Beta activity reached with
NF: older and more intelligent children enhance Beta fre-
quencies more strongly with treatment, but no analysis was
performed in regard to clinical response [56]. Electrophys-
iological studies also provide additional evidence that some
people are not able to gain control over brain electric activ-
ity through NF. Doehnert et al. [62] used quantitative resting
EEG to examine if SCP NF versus group therapy would
change CNV. No significant group by time interaction was
found, but good NF performers had less pronounced CNV
reduction [62]. A significant increase of positive ERPs
components over frontal–central areas within the 180-
420 ms latency range, possibly reflecting an activation of
frontal cortical areas associated with 20 sessions of beta NF
training, was found in another study using a Go/No-Go task
for good, but not for bad performers [63]. Parents’ attitudes
in regard to children have also been found to predict treat-
ment response to NF. Participants whose parents use con-
sistently reinforcing strategies have significant larger
reductions of symptoms after NF [44], suggesting that at
least in part, the effect of NF depends on factors not directly
related to the training itself. It should be also noted that the
vast majority of studies included male, school age children
with ADHD combined subtype (see Tables 1, 2 and 3 for
details). Thus, it is uncertain if NF works for adults, pre-
schoolers, females, or other ADHD subtypes. The only study
that included a majority of female subjects was the one
with healthy adult academics [17], and authors failed to
find positive results favoring NF in comparison with
sham-NF, but no conclusive data exist to evaluate if women
are less prone than man to respond to NF. Recently, a pre-
post NF trial with adults with ADHD was published with
encouraging preliminary results. After 15 sessions of NF,
patients showed significant improvement of ADHD self-
reported symptoms and a tendency for increased CNV
amplitude [49]. It would be interesting to test the effects
of NF for pre-schoolers because young children are less
susceptible to benefit from stimulants [64] and the remis-
sion rate with behavioral therapy (as a first-line treatment)
is also low [65]. However, pilot work needs to establish
whether young children can regularly and for long enough
attend and control artifacts to learn self-regulation.
Safety and Tolerability of NF for ADHD
Although it is regularly assumed that NF treatment does not
cause side effects, only three studies systematically
addressed this question. In these studies, no safety issues
emerged [14, 19, 20] concerning sleep problems, tics, skin
picking, headache, stomach ache, irritability, appetite loss,
seizures, nausea, or feelings of agitation. In general, dropout
rates from NF studies are very low and no discontinuation
due to side effects are reported in clinical trials.
Is Long-Term NF Effective?
Very few studies examined the long-term effect of NF, but
the few studies that did it found promising results. Gani et
al. [66] conducted a 2-year follow-up of 23 of 47 children
that have participated in a controlled trial in which subjects
were randomized to SCP or frequency training. Two years
after the end of the study, the behavioral and attentional
improvements were maintained and some additional bene-
fits could be seen, suggesting that patients were still im-
proving even after the end of treatment. Gevensleben et al.
[60] found similar results in the 6-month follow-up of their
randomized controlled trial comparing NF to CAST. Sixty-
five percent of participants were followed, and improve-
ments in the NF group were superior to the control group
and comparable to that of the end of the active treatment
phase. At first glance, it can sound unreasonable that
patients can continue to improve after treatment interrup-
tion; nevertheless, it is consistent with NF rationale. The aim
of NF training is not only to promote the specific modifica-
tion on the EEG pattern that is programmed to be rewarded
(e.g., to enhance Beta activity), but it is to teach individuals
that it is possible to gain control over mental states and to
develop strategies to perceive and modify it in accordance
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with self control. An important part of the EEG treatment is
“transfer training.” In other words, the training to transfer
the skills acquired in the NF protocol to daily life. The two
German trials that reported the 2 years and 6-month follow-
up data previously described used transfer training to reach
generalization of regulatory skills to everyday life [38, 39].
In those 2 studies, transfer training was applied as follows:
in 23 % of trials patients did not receive immediate feed-
back, but had to guess if they were performing right or
wrong for 8 seconds before they received feedback. In
addition, from the 8th session onward, patients had to prac-
tice their strategy to remain “activated” for at least
10 minutes a day on some daily life task that require them
to be attentive like doing the homework or playing a game.
Children were instructed to identify situations in which
these strategies would be important and to increase their
attention control strategies [39]. In conclusion, available
data suggest that NF is effective long-term, but it is possible
that the long-term effects of NF depend on the generaliza-
tion of regulatory skills to daily life.
What Treatment Protocol is the Best?
Frequency training and SCP are the most commonly used
treatment protocols for ADHD. Some authors have hypoth-
esized that frequency training would be better for improving
tonic aspects of cortical arousal, whereas SCP would be
preferable for enhancing phasic regulation of attentive be-
havior [39]. SCP protocols tend to be more homogeneous,
but several different treatment protocols have been proposed
for frequency training. Tables 1, 2, and 3 describe character-
istics of the different protocols used in controlled trials in
regard to the target frequency band, the electrode placement,
the number, duration, and frequency of sessions. However,
there is no controlled scientific data on the direct compari-
son of different frequency protocols. Arns et al. [16] found
no difference for the effect size of studies using different
protocols (SMR/Theta, SRM/Beta/Theta, and SCP). SCP
has been compared to Theta/Beta training in 2 randomized
controlled trials and both protocols showed to be equally
effective for behavioral and cognitive improvements [38,
39]. One important difference between treatment protocols
is whether they are individualized or standardized. The
majority of clinical trials use standardized protocols. As
standardization of all procedures is the regular practice in
research, we do not have enough empirical data to assure the
efficacy of personalized methods planned in accordance
with each individual EEG pattern. Nevertheless, recently a
small, open-label pilot study showed a significant clinical
improvement and electrophysiological normalization after
neurofeedback sessions [67]. This is compatible with em-
pirical data showing that different behavioral profiles of
children with ADHD present different patterns of EEG
activity [34]. In summary, no conclusive data exist support-
ing the superiority of any of the available protocols.
In addition, there are scarce data on the minimum number
of sessions needed for optimal results. Arns et al.’s [16]
meta-analysis found a significant correlation between ES
and treatment duration (i.e., the average number of sessions)
only for improvement of inattention, but not for impulsivity
and hyperactivity. However, a naturalistic quasi-experiment
that included a large set of 1089 patients undergoing NF
treatment found a statistically significant superiority of 40
sessions in comparison with 20 sessions for impulse control
and response consistency in a continuous performance test
[68]. Nevertheless, performance on neuropsychological
tests may benefit from training, and this result can reflect
not necessarily improvement but learning. In addition, a
controlled study monitored symptoms improvement along
40 sessions of NF and could not find any additional im-
provement after session 24 [20].
Is There Evidence for the Use of NF as a Monotherapy
for ADHD?
NF has been proven to be efficacious in the vast majority of
trials conducted so far, but there is not enough data to
support the use of NF as a monotherapy for ADHD. The
great majority of studies tested NF as an adjunctive treat-
ment, and for ethical reasons other treatments are usually not
discontinued. Although only a minority of patients included
in the studies are receiving medication (12 % of the 973
patients included in Arns’ meta-analysis [16]), psychoedu-
cation and other psychosocial treatment are regularly
allowed. Monastra et al. [44] compared NF combined with
a multimodal treatment (comprising methylphenidate,
parents counseling, and academic support) to the multimod-
al treatment itself. After the treatment phase, children were
assessed with and without the ongoing stimulant therapy
and results showed that both groups improved comparably,
but only children in the NF group sustained the gains after
medication washout. This may suggest that the association
of NF to other treatments has the potential to consolidate
achieved gains allowing medication to be withdrawn after
awhile. Studies investigating not only the effectiveness of
NF, but also the best scenario for its use are needed.
Conclusions and Future Directions
In conclusion, although the first positive trials for the use of
NF for ADHD were published in the 1970s, well-designed,
randomized controlled studies have been conducted only in
recent years. Although some data suggest possible efficacy
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and specificity of NF for the treatment of ADHD, considerable
work is still needed to determine the contribution of specific in
comparison to nonspecific components, when and how to use
NF in routinely clinical practice, and how to implement NF
standards covering the fidelity of the EEG and artifact control
methodology, as well the behavioral therapy aspects. Never-
theless, in specific settings, depending on parents and children
preferences and on the acceptance for other treatment, NF
provides a valuable alternative.
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